Rhabdomyolysis and COVID-19

This paper seeks to summarize recent research findings concerning the link between rhabdomyolysis and COVID-19. While most commonly known as a respiratory disease, COVID-19 has strong direct effects on the kidneys which presents a serious challenge to treatment and care of patients. New research also suggests that COVID-19 directly damages skeletal muscle tissue as well, and rhabdomyolysis induced as a result of viral attack or secondary factors can also place major strain on the kidneys. Both COVID-19 and rhabdomyolysis can lead to acute kidney injury on their own, and their combined effects can present severe clinical complications. This body of research must be developed further in order to inform patient care techniques and adapt to further mutations in the SARS-CoV-2 virus as the pandemic continues